Skin reactions due to low molecular weight heparin in pregnancy: A strategic dilemma

Archives of Gynecology and Obstetrics

Volumn 271, Issue 2, 2005, Pages 163-165

  Verdonkschot, A E M ^a   Vasmel, W L E ^b   Middeldorp, S ^a   Van Der Schoot, J T M ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

Author keywords

Allergy; Delayed hypersensitivity; Low molecular weight heparin; Pregnancy

Indexed keywords

CHLORBUTOL; DALTEPARIN; DANAPAROID; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DEEP VEIN THROMBOSIS; DELAYED HYPERSENSITIVITY; DISEASE COURSE; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; EDEMA; ERYTHEMA; FEMALE; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; INJECTION SITE REACTION; INTRACUTANEOUS TEST; PREGNANCY; PRURITUS; SKIN INDURATION; SKIN MANIFESTATION; TREATMENT FAILURE;

ADULT; ANTICOAGULANTS; DRUG ERUPTIONS; FACTOR V; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; PREGNANCY; PULMONARY EMBOLISM; VENOUS THROMBOSIS;

EID: 16444387599     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00404-004-0615-0     Document Type: Article

References (11)

1. Brill-Edwards P, Ginsberg JS, Gent M, Hirsch J, Burrows R, Kearon C, Geerts W, Kovacs M, Weitz JI, Robinson KS, Whittom R, Couture G (2000) Safety of withholding heparin in pregnant women with a history of venous thromboembolism. Recurrence of clot in this pregnancy group. N Engl J Med 343:439-444
2. Ginsberg JS, Greer I, Hirsch J (2001) Use of antithrombotic agents during pregnancy. 119 [Suppl 1]:122S-131S
3. Hawkins DF (ed) (1987) Drugs and pregnancy (human teratogenesis and related problems). Churchill Livingstone, London, pp 166-167
4. Hirsch J, Weitz JI (1999) New antithrombotic agents. Lancet 353:1431-1436
5. Hunzelmann N, Gold H, Scharffetter-Kochanek K (1998) Concomitant sensitization to high and low molecular-weight heparins, heparinoid and pentosanpolysulfate. Contact Dermatitis 39:88-89
6. Klein GF, Kofler H, Wolf H, Fritsch PO (1989) Eczema-like, erythematous, infiltrated plaques: a common side effect of subcutaneous heparin therapy. J Am Acad Dermatol 21:703-707
7. Naravan H, Cullimore J, Krarup K, Thurston H, Macvicar J, Bolia A (1992) Experience with the cardial inferior vena cava filter as prophylaxis against pulmonary embolism in pregnant women with extensive deep venous thrombosis. Br J Obstet Gynaecol 99:637-640; erratum Br J Obstet Gynaecol 99:726
8. Plancherel P (1952) Klinische und gerinnungsphysiologische Untersuchungen mit einem neuen Heparindepotpräparat. Z Klin Med 150:213-259
9. Sanson BJ, Lensing AW (1999) Safety of low-molecular-weight-heparin in pregnancy: a systematic review. Thromb Haemost 81:668-672
10. Schulman S (1996) Anticoagulation in venous thrombosis. J R Soc Med 624-630
11. Wesseling J, van Driel D, Smrkovsky M, van der Veer E, Geven-Boere LM, Saner PJ, Touwen BC (2001) Neurological outcome in school-age children after in utero exposure to coumarins. Early Hum Dev 63:83-95